Zinzino (ZZ B)
In this equity research report, analysts Carl Viktor Wümer and Sebastian Wester take a closer look at the Swedish dietary supplement company Zinzino (ZZ B). The analysts estimate a revenue CAGR of 13.7% between 2021A-2023E, largely driven by Zinzino’s ability to expand to new submarkets through its efficient direct selling business model.
